Quantitative in silico Analytical Chemistry
21世紀　分析化学教室

2024-0915 Visualization XXXIII Against chronic kidney disease.pdf (1.09MB)

2024-0825 Visualization XXXII Covid-19 updated 3 Natural infection inhibitors.pdf (1.33MB)

2024-0815 Visualization XXXI Covid-19 updated 2 Practical use of current medicines.pdf (2.81MB)

2024-0805 Visualization XXX Covid-19 updated 1 Fundamental and Inhibition.pdf (1.93MB)

2024-0629 Visualization XXVII KP.2 and KP.3 binding with ACE-2.pdf (0.26MB)

 2024-0520 Visualization XXII JN.1 S-RBD and ACE-2 interaction inhibitors.pdf (0.58MB)

2024-0510 Visualization XXI Enantimers^LJ the wonderland.pdf (0.4MB)

2024-0503 Visualization XX Glycosylation Efective derivatization.pdf (0.72MB)

2024-0430 Visualization XIX Quantitative analysis of enzyme selectivity.pdf (0.18MB)

2024-0420 Binding inhibitor 18 RNA medicine candidates for kidney disease patients.pdf (0.31MB)

2024-0404 Binding inhibitors 17 Visualization XVII Selectivity of inhibitors against variants Delta, BA.2.86, and JN.1.pdf (0.48MB)

2024-0326 Binding inhibitor16, Quick search for advanced medicines.pdf (0.19MB)

2024-0320 Binding inhibitor 15 Advanced medicines.pdf (0.28MB)

2024-0305 Binding inhibitos 14 AI and auto dock.pdf (0.33MB)

2024-0222 Binding inhibitors 13 Chemical structure of binding inhibitors 2 Contribution of glycoside.pdf (0.34MB)

2024-0216 Binding inhibitors 12.pdf (0.36MB)

2024-0208 Binding inhibitors 11.pdf (0.4MB)

2024-0121 Binding inhibitors 10.pdf (0.48MB)

2024-0106 Binding inhibitos 9.pdf (0.44MB)

2023-1224 Bonding inhibitos 8.pdf (0.27MB)

2023-1222 Binding inhibitors 7.pdf (0.3MB)

2023-1122 Binding inhibitors 6.pdf (0.78MB)

2023-1103 Bonding inhibitors 5 Tea components.pdf (0.29MB)

2023-0916 Binding inhibitors 4.pdf (0.33MB)

2023-0825 Binding inhibitors 3.pdf (0.7MB)

2023-0815 Binding inhibitors 2.pdf (0.2MB)

2023-0808 Binding inhibitors.pdf (0.22MB)

2024-0915 Visualization XXXIII Against chronic kidney disease.pdf (1.09MB)

2024-0727 Visualization XXIX Biomarker for senile dementia 3.pdf (0.37MB)

2024-0720 Visualization XXVIII Biomarker for senile dementia 2.pdf (0.27MB)

2024-0622 Visualization XXVI Biomarker for senile dementia 1.pdf (0.17MB)

2024-0614 Visualization XXV Biomarker for Kidney disease 3 Creatine Kinase.pdf (0.34MB)

2024-0604 Visualization XXIV Biomarker for Kidney Disease 2 Guanidinoacetic acid N-methyltransferase.pdf (0.34MB)

Visualization XXIII Biomarker for Kidney Disease 1, Glycine amidinotransferase.pdf (0.48MB)

2024-0510 Visualization XXI Enantimers^LJ the wonderland.pdf (0.4MB)

2024-0430 Visualization XIX Quantitative analysis of enzyme selectivity.pdf (0.18MB)

2024-0420 Binding inhibitor 18 RNA medicine candidates for kidney disease patients.pdf (0.31MB)

2024-0326 Binding inhibitor16, Quick search for advanced medicines.pdf (0.19MB)

2024-0320 Binding inhibitor 15 Advanced medicines.pdf (0.28MB)

Advanced quantitative in silico chromatography of natural and synthesized phases.pdf (4.48MB)

Supplemental Preparation and evaluation of chemically stable bonded-phase silica gels.pdf (1.38MB)

Evaluation of column test methods to study inactivation of chemically bonded silica gels.pdf (0.65MB)

In silico analytical chemistry cover.pdf (2.07MB)

Prefase Aknowledgements Contents.pdf (0.36MB)

Chapter 1 Molecular Properties for in silico Analysis.pdf (1.22MB)

Chapter 2 Fundamental Molecular Interaction Mechanisms .pdf (4.42MB)

Chapter 3 Modeling Analysis Cf chromatographic Retention.pdf (5.15MB)

Chapter 4 Quantitative Explanation of Spectra.pdf (2.04MB)

Chapter 5 Preparation of Model Phases.pdf (4.47MB)

Chapter 6 Quantitative Explanation of Retention Mechanisms and Solvent Effects.pdf (2.64MB)

Chapter 7 Quantitative Analysis of the Retention in Liquid Chromatography.pdf (4.9MB)

Chapter 8 Enantiomer Recognition.pdf (4.32MB)

Chapter 9 Physical Biochemistry of Enzyme Reactions.pdf (5.48MB)

Chapter 10 Protein-protein Interactions, SARS COVID-19 Variants Transmissibility and the Binding Inhivitors.pdf (7.29MB)

Index.pdf (0.16MB)

目次N.pdf (0.56MB)

1. はじめに.pdf (0.73MB)

２計算化学で分子の構築 .pdf (1.01MB)

3. 液体クロマトグラフィー１　グラファイトカーボン相の構築.pdf (0.99MB)

4. 液体クロマトグラフィー2、グラファイトカーボン相への保持の定量解析.pdf (1.21MB)

5. ガスクロマトグラフィー１　メチルシリコン相の構築と保持比との関係.pdf (1.18MB)

6. ガスクロマトグラフィー２　沸点とエンタルピー.pdf (0.75MB)

7. ガスクロマトグラフィー3　エチレングリコール (カーボワックス) 相の構築と保持比との関係.pdf (0.87MB)

8. ガスクロマトグラフィー4　50^1フェニルメチル相の構築と保持比との関係.pdf (1.57MB)

9. 順相液体クロマトグラフィーに於ける保持機構.pdf (1.09MB)

10. 親水性相互作用液体クロマトグラフィーに於ける保持機構.pdf (0.86MB)

11. イオン交換液体クロマトグラフィーに於ける保持機構.pdf (0.8MB)

12. 液体クロマトグラフィーに於ける溶媒効果 1.pdf (0.99MB)

13. 液体クロマトグラフィーに於ける溶媒効果 2.pdf (0.75MB)

14. 滴定分析1、フェノールフタレインの色の変化.pdf (0.73MB)

15. 指示薬スルフォフタレインの色の変化.pdf (0.59MB)

16. 滴定分析3．メチルオレンジ、メチルレッドの色の変化.pdf (1.11MB)

17. 比色分析 ヒドロクロロチアジドの純度試験及びクレアチニンの定量の為の誘導体化.pdf (0.67MB)

18. NMR スペクトルの解析.pdf (1.16MB)

19. 化学発光高感度検出とイオンクロマトグラフィーに於ける光吸収ブロメイトの検出.pdf (1.07MB)